Lumentum Showcases Next-Generation Ultrafast and UV Laser Platforms for Precision Manufacturing at Photonics West 2026

Lumentum Showcases Next-Generation Ultrafast and UV Laser Platforms for Precision Manufacturing at Photonics West 2026

SAN JOSE, Calif.–(BUSINESS WIRE)–
Lumentum Holdings Inc. (“Lumentum”), a market-leading designer and manufacturer of optical and photonic products, announced today its participation in SPIE Photonics West 2026, where it will showcase high-power ultrafast, UV, and 3D sensing laser solutions designed to meet the growing precision, throughput, and reliability demands of advanced manufacturing and sensing applications.

Attendees are invited to visit Lumentum booth #2343 at the San Francisco Moscone Center from January 20-22, where the company will demonstrate how its latest laser and photonic innovations are driving new levels of precision, scalability, and integration across advanced manufacturing applications.

Featured products include:

  • PicoBlade® Core – Lumentum’s latest ultrafast laser platform delivers up to 150 watts of average power with sub-12 picosecond pulses and integrated multi-wavelength output in a compact, unified design. It enables high-throughput, precision micromachining for printed circuit boards, battery cells, solar cells, and consumer electronics applications. The platform is available in NIR, Green and UV wavelengths.
  • NQ-Series – The newest addition to Lumentum’s nanosecond-pulsed laser portfolio, the NQ-Series delivers up to 500 µJ pulse energy of UV light at rates up to 60 kHz. Designed for high-throughput micromachining, the NQ-Series brings exceptional beam quality and reliability to address next-generation processing challenges.
  • 3D Sensing VCSELs – Lumentum offers a broad portfolio of vertical-cavity surface-emitting laser (VCSEL) solutions supporting 3D sensing across a wide range of industrial and consumer applications. Scalable, high-volume manufacturing ensures consistent performance, high reliability, and power efficiency for use cases including depth sensing, object detection, and driver assistance systems.

“Manufacturers are being pushed to achieve tighter tolerances while simultaneously increasing throughput and uptime,” said Matt Philpott, vice president of business development at Lumentum. “Our latest ultrafast and nanosecond-pulsed laser platforms are designed to address that challenge directly— combining higher average power, precise pulse control, and proven reliability to enable scalable, production-ready micromachining across demanding applications.”

About Lumentum

Lumentum (NASDAQ: LITE) is a market-leading designer and manufacturer of innovative optical and photonic products enabling optical networking and laser applications worldwide. Lumentum optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum lasers enable advanced manufacturing techniques and diverse applications, including next-generation 3D sensing capabilities. The company is headquartered in San Jose, California, with R&D, manufacturing, and sales offices worldwide. For more information, visit www.lumentum.com.

Category: Financial

Media: Victoria McDonald, +1.408.404.0636; [email protected]

Investors: Kathy Ta, +1.408.750.3853; [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Engineering Technology Manufacturing Other Technology Software Other Manufacturing Hardware

MEDIA:

Logo
Logo

Class Action Filed Against Blue Owl Capital Inc. (OWL) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Blue Owl Capital Inc. (“Blue Owl Capital Inc.” or the “Company”) (NYSE: OWL) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Blue Owl Capital Inc. investors who were adversely affected by alleged securities fraud between February 6, 2025 and November 16, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/blue-owl-capital-inc-lawsuit-submission-form?prid=183135&wire=3

OWL investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Blue Owl was experiencing a meaningful pressure on its asset base from business development companies’ redemptions; (2) as a result, the Company was facing undisclosed liquidity issues; (3) as a result, the Company would be likely to limit or halt redemptions of certain business development companies; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT’S NEXT? If you suffered a loss in Blue Owl Capital Inc. during the relevant time frame, you have until February 2, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Levi & Korsinsky Notifies Varonis Systems, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – VRNS

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Varonis investors who were adversely affected by alleged securities fraud between February 4, 2025 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/varonis-systems-inc-lawsuit-submission-form?prid=183132&wire=3

VRNS investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Varonis’ ability to convert its existing customer base; notably, that it was not truly equipped to convince existing users of the benefits of converting to the SaaS offering or otherwise maintain those customers on its platform, resulting in significantly reduced ARR growth potential in the near-term. On October 28, 2025, Varonis announced its financial results for the third quarter of fiscal 2025, disclosing a significant miss to ARR and reducing its projections for the full fiscal year 2025, despite previously uplifting guidance for the previous two consecutive quarters. The Company attributed its results and lowered guidance on weaker than expected renewals and conversions in their federal and non-federal on-premises subscription business. Varonis further resultantly announced the end of life of the self-hosted solution and a 5% headcount reduction. Following this news, Varonis’ common stock declined dramatically. From a closing market price of $63.00 per share on October 28, 2025, Varonis’ stock price fell to $32.34 per share on October 29, 2025, a decline of about 48.67% in the span of just a single day.

WHAT’S NEXT? If you suffered a loss in Varonis during the relevant time frame, you have until March 9, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Coupang, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before February 17, 2026 to Discuss Your Rights – CPNG

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Coupang, Inc. (“Coupang, Inc.” or the “Company”) (NYSE: CPNG) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Coupang, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and December 16, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/coupang-inc-lawsuit-submission-form?prid=183139&wire=3

CPNG investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Coupang had inadequate cybersecurity protocols that allowed a former employee to access sensitive customer information for nearly six months without being detected; (2) this subjected Coupang to a materially heightened risk of regulatory and legal scrutiny; (3) When defendants became aware that Coupang had been subjected to this data breach, they did not report it in a current report filing (to be filed with the U.S. Securities and Exchange Commission (the “SEC”)) in compliance with applicable reporting rules; and (4) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Coupang, Inc. during the relevant time frame, you have until February 17, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



FRMI LAWSUIT ALERT: Levi & Korsinsky Notifies Fermi Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fermi Inc. (“Fermi Inc.” or the “Company”) (NASDAQ: FRMI) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fermi Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Fermi: (a) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s October 2025 initial public offering; and/or (b) securities between October 1, 2025 and December 11, 2025, inclusive. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/fermi-inc-lawsuit-submission-form?prid=183142&wire=3

FRMI investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company overstated its tenant demand for its Project Matador campus; (2) the extent to which Project Matador would rely on a single tenant’s funding commitment to finance the construction of Project Matador; (3) there was a significant risk that that tenant would terminate its funding commitment; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT’S NEXT? If you suffered a loss in Fermi Inc. during the relevant time frame, you have until March 6, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Levi & Korsinsky Reminds SLM Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 17, 2026 – SLM

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in SLM Corporation (“SLM Corporation” or the “Company”) (NASDAQ: SLM) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of SLM Corporation investors who were adversely affected by alleged securities fraud between July 25, 2025 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/slm-corporation-lawsuit-submission-form?prid=183138&wire=3

SLM investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) SLM was experiencing a significant increase in early stage delinquencies; (ii) accordingly, defendants overstated the effectiveness of SLM’s loss mitigation and/or loan modification programs, as well as the overall stability of the Company’s private education loan delinquency rates; and (iii) as a result, defendants’ public statements made a materially false and misleading impression regarding SLM’s business, operations, and prospects at all relevant times.

WHAT’S NEXT? If you suffered a loss in SLM Corporation during the relevant time frame, you have until February 17, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Shareholders that lost money on agilon health, inc.(AGL) should contact Levi & Korsinsky about pending Class Action – AGL

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in agilon health, inc. (“agilon health, inc.” or the “Company”) (NYSE: AGL) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/agilon-health-inc-lawsuit-submission-form?prid=183141&wire=3

AGL investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware; (2) defendants materially overstated the immediate positive financial impact from “strategic actions” taken by agilon to reduce risk; and (3) as a result, defendants’ statements about agilon’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT’S NEXT? If you suffered a loss in agilon health, inc. during the relevant time frame, you have until March 2, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Shareholders of Klarna Group plc Should Contact Levi & Korsinsky Before February 20, 2026 to Discuss Your Rights – KLAR

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Klarna Group plc (“Klarna Group plc” or the “Company”) (NYSE: KLAR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Klarna Group plc investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons who purchased or otherwise acquired Klarna securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Klarna’s initial public offering on September 10, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/klarna-group-plc-lawsuit-submission-form?prid=183140&wire=3

KLAR investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants materially understated the risk that its loss reserves would materially go up within a few months of the IPO, which they either knew of or should have known of given the risk profile of many individuals agreeing to Klarna’s buy now, pay later loans; and (2); as a result, defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.

WHAT’S NEXT? If you suffered a loss in Klarna Group plc during the relevant time frame, you have until February 20, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Class Action Filed Against Perrigo Company plc (PRGO) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Perrigo Company plc (“Perrigo Company plc” or the “Company”) (NYSE: PRGO) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perrigo Company plc investors who were adversely affected by alleged securities fraud between February 27, 2023 and November 4, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/perrigo-company-plc-lawsuit-submission-form?prid=183133&wire=3

PRGO investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) Perrigo needed to make substantial capital and operational expenditures above the Company’s outwardly stated cost estimates to remediate the infant formula business; (3) there were significant manufacturing deficiencies in the facility for the Company’s infant formula business; (4) as a result of the foregoing, the Company’s financial results, including earnings and cash flow, were overstated; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT’S NEXT? If you suffered a loss in Perrigo Company plc during the relevant time frame, you have until January 16, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Skye Bioscience, Inc.(SKYE) Shareholders

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. (“Skye Bioscience, Inc.” or the “Company”) (NASDAQ: SKYE) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Skye Bioscience, Inc. investors who were adversely affected by alleged securities fraud between November 4, 2024 and October 3, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/skye-bioscience-inc-lawsuit-submission-form?prid=183130&wire=3

SKYE investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i)The Company’s lead product candidate, nimacimab, was less effective than defendants had led investors to believe; (ii) accordingly, nimacimab’s clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Skye Bioscience, Inc. during the relevant time frame, you have until January 16, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com